|
|
||||||||
The Annals of Thoracic Surgery, Vol 46, 172-177, Copyright © 1988 by The Society of Thoracic Surgeons
CM Conklin, RJ Gray, D Neilson, P Wong, DK Tomita and JM Matloff
In this open-label, randomized drug study, we compared two cephalosporin
prophylactic regimens, one using cefazolin and one using cefuroxime, in 100
patients having coronary bypass surgery. Additional epidemiological data
were collected to identify the patient at higher risk for acquiring an
infection. Patients were categorized into four groups: (1) no infection;
(2) clinically determined infection without a culture or prescription of
additional antibiotics; (3) clinical infection with no or negative wound
culture and prescription of additional antibiotics; and (4) clinical
infection with positive culture and need for additional antibiotics. Seven
cefuroxime patients (13.5%) and 9 cefazolin patients (18.8%; p = 0.471) had
a wound that became clinically infected (Groups 2-4). In a univariate
analysis, 11 variables were statistically associated with the development
of a wound infection. A logistic regression model defined 3 variables at an
alpha level of 0.05 and 3 at an alpha level of 0.10 that predicted a wound
infection. Patients were identified at high risk of wound infection if they
had postoperative weight gain, long operative hospitalization, prolonged
use of a Foley catheter, postoperative use of blood products, and operation
performed by two specific surgeons. Our results indicated that closer
observation of the high-risk patients and a definition of the mechanism of
the infections are needed.
ARTICLES
Determinants of wound infection incidence after isolated coronary artery bypass surgery in patients randomized to receive prophylactic cefuroxime or cefazolin
Department of Thoracic and Cardiovascular Surgery, Cedars-Sinai Medical Center, Los Angeles, CA 90048.
This article has been cited by other articles:
![]() |
R. Garland, F.A. Frizelle, B.R. Dobbs, and H. Singh A retrospective audit of long-term lower limb complications following leg vein harvesting for coronary artery bypass grafting Eur. J. Cardiothorac. Surg., June 1, 2003; 23(6): 950 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Chelemer, B. S. Prato, P. M. Cox Jr, G. T. O'Connor, and J. R. Morton Association of bacterial infection and red blood cell transfusion after coronary artery bypass surgery Ann. Thorac. Surg., January 1, 2002; 73(1): 138 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bellchambers, J.M. Harris, P. Cullinan, H. Gaya, and J.R. Pepper A prospective study of wound infection in coronary artery surgery Eur. J. Cardiothorac. Surg., January 1, 1999; 15(1): 45 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Y. Bitkover and B. Gardlund Mediastinitis After Cardiovascular Operations: A Case-Control Study of Risk Factors Ann. Thorac. Surg., January 1, 1998; 65(1): 36 - 40. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |